PATH vs XYL · P/E 19, rev $1.61B vs P/E 27, rev $8.56B
Uipath Inc (PATH) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported XYL revenue for 2024-12-31 was $8.56B. Net income was $890.0M. Revenue was up 16.3% from 2023-12-31 to 2024-12-31. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the PATH and XYL stock pages for the full models.
Not investment advice.